Exercise intolerance in chronic heart failure: mechanisms and therapies. Part I. - Wikidata - awgldk - TriplyDB

Exercise intolerance in chronic heart failure: mechanisms and therapies. Part I.

Exercise intolerance in chronic heart failure: mechanisms and therapies. Part I.

http://www.wikidata.org/entity/Q37832481

about

3D False Color Computed Tomography for Diagnosis and Follow-Up of Permanent Denervated Human Muscles Submitted to Home-Based Functional Electrical Stimulation HDAC6 contributes to pathological responses of heart and skeletal muscle to chronic angiotensin-II signaling.Correlation between changes in diastolic dysfunction and health-related quality of life after cardiac rehabilitation program in dilated cardiomyopathy.Effect of aerobic training on heart rate recovery in patients with established heart disease; a systematic review.Modifications of skeletal muscle ryanodine receptor type 1 and exercise intolerance in heart failure.Muscle oxygen transport and utilization in heart failure: implications for exercise (in)tolerance.Pulmonary congestion at rest and abnormal ventilation during exercise in chronic systolic heart failure.Do heart failure status and psychosocial variables moderate the relationship between leisure time physical activity and mortality risk among patients with a history of myocardial infarction?Maximal oxygen uptake and exercise tolerance are improved in rats with heart failure subjected to low-level laser therapy associated with resistance training.Exercise training in chronic heart failure: improving skeletal muscle O2 transport and utilization.Skeletal muscle microvascular oxygenation dynamics in heart failure: exercise training and nitric oxide-mediated function.Cardio-selective beta-blocker: pharmacological evidence and their influence on exercise capacity.Exercise as a nonpharmacologic intervention in patients with heart failure Impact of overt and subclinical hypothyroidism on exercise tolerance: a systematic review.Cardiopulmonary exercise testing in systolic heart failure in 2014: the evolving prognostic role: a position paper from the committee on exercise physiology and training of the heart failure association of the ESC.Assessing quality-of-life outcomes in cardiovascular clinical research.Vascular KATP channels mitigate severe muscle O2 delivery-utilization mismatch during contractions in chronic heart failure rats.High-intensity interval and endurance training are associated with divergent skeletal muscle adaptations in a rodent model of hypertension.Heart failure special edition.The 'skeletal muscle hypothesis in heart failure' revised.Aerobic training and angiogenesis activation in patients with stable chronic heart failure: a preliminary report.Functional capacity in a rat model of heart failure: impact of myocardial infarct size.Exercise performance, haemodynamics, and respiratory pattern do not identify heart failure patients who end exercise with dyspnoea from those with fatigue.Is there any benefit using low-intensity inspiratory and peripheral muscle training in heart failure? A randomized clinical trial.Examining the relationship between exercise tolerance and isoproterenol-based cardiac reserve in murine models of heart failure.Back to the future: re-evaluation of the possible role for oxygen supplementation during exercise in chronic heart failure.Impact of exercise training on adverse event risk and quality of life in patients with heart failure.Age-related impact of depressive symptoms on functional capacity measured with 6-minute walking test in coronary artery disease.The effects of dietary fish oil on exercising skeletal muscle vascular and metabolic control in chronic heart failure rats.Exercise performance of chronic heart failure patients in the early period of support by an axial-flow left ventricular assist device as destination therapy.

P2860

Q26766433-7758492A-7DB7-4A16-8F1C-0E878DE880C5 Q33913127-E335DADE-D9DA-415B-B87D-3EEE6DA865B9 Q34330971-E68F6CC2-1777-40CB-A92C-C9AB0BF83137 Q35075621-4730F05C-A8CC-452F-BA1C-6FBE2EAB4E92 Q35447198-3EE1464C-A9E0-4389-B14E-66039C47C3DA Q35850050-90DCCA4D-944A-44EE-8967-599A84F3E068 Q36141321-C7260ACA-5EEA-4E72-9CE1-8DDB39443BEC Q36161706-BB4D1F4D-B91B-453C-A5BF-B367EA2F70B7 Q36196235-4410ACA2-4FB6-4A77-9366-83F7B69037CE Q36339431-3FCE7322-C348-4CE4-A2A6-F3EAC8A3230D Q37629263-43E43B87-7B4D-40B5-9C0E-1552D0C270EE Q37978886-57A31AB2-B21E-44C9-88BA-73127B6B2255 Q37980343-B6E482E1-194D-43D1-9809-D37B9E601F10 Q38241623-6736C814-56E8-49DF-B4E9-27E74F0D391A Q38245121-97F10082-DD4C-45FE-8CED-96B067B23F58 Q38737960-190E9437-3FCD-4D49-8536-F1E07058DAFD Q39001287-D6159AAC-50A9-4600-BFB6-3BC6DBC86198 Q41099304-FD76552F-2DB9-4C75-B73B-F21877F51893 Q42325575-57D0A869-7655-44AE-98AA-2E7A84AA8C9A Q44524438-19EFC3B8-42D9-40FA-AD73-7762CEEDD1CF Q46622856-F959A556-1F86-492F-8A64-2DFF52182F4A Q47192112-CA1AA78F-C193-4989-8407-6A65EF20B306 Q47420376-53BC4467-C2DE-41A9-88BE-A5A99DE7070A Q47960608-08D40A59-FF6D-44FF-B55A-38A7B4F8F0D0 Q48031125-47DB6771-DC28-47CA-A1AE-530697E413CD Q48210033-36D65B80-FB4A-4475-BC0A-DBFF55C79772 Q48394412-A5F61AA8-3338-4714-8A6B-9411F7F6D7B5 Q48459434-622236FC-DB64-4F0B-85C0-A18782B3510F Q54301411-1145CB08-61D0-4CCE-BF84-700315EF49FC Q54777166-104E8BB2-E740-4B67-B1A5-1D002CB3A86F

P2860

Exercise intolerance in chronic heart failure: mechanisms and therapies. Part I.

http://www.wikidata.org/entity/Q37832481

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Exercise intolerance in chronic heart failure: mechanisms and therapies. Part I.

@en

Exercise intolerance in chronic heart failure: mechanisms and therapies. Part I.

@nl

type

label

Exercise intolerance in chronic heart failure: mechanisms and therapies. Part I.

@en

Exercise intolerance in chronic heart failure: mechanisms and therapies. Part I.

@nl

prefLabel

Exercise intolerance in chronic heart failure: mechanisms and therapies. Part I.

@en

Exercise intolerance in chronic heart failure: mechanisms and therapies. Part I.

@nl

P1433

Q37832481-652E85B4-B5F1-4FF9-9D38-99A1B49CCB06

P1476

Q37832481-72846F0D-3706-4C9B-8F0A-9017CE4C94D9

P2093

Q37832481-0E6C95EC-FBEF-44E4-96C1-2B707393A4C7

Q37832481-105552C9-F7B6-4E42-A007-B8F1CB87AE6A

Q37832481-16527FC0-3F58-40B0-AE8D-4EE21D9BB526

Q37832481-32CB8C12-9E37-49B2-98FE-534A503DCF2F

Q37832481-4722C992-E72B-4C50-A94A-E2E12E93D8FF

Q37832481-96730FB8-850E-46B7-A5A3-A345F909A728

Q37832481-9B495568-8861-4B1F-B699-EEEE1D2F9AC9

Q37832481-E66C09CC-EB4C-4E50-99DA-AB968AAF6AF2

Q37832481-FBA5C576-6250-430F-A310-C75137ABDD4A

P2860

Q37832481-0362779A-EF87-49FB-A34C-75A1B8BB8EFD

Q37832481-12B6E418-D278-442D-A20B-DDAA98EF56FE

Q37832481-206586D7-02ED-4943-B420-F67B26F9EA86

Q37832481-208DA493-A805-4758-9A56-F483EE28EC0B

Q37832481-2A97C456-9D3A-408C-9699-057525FF5778

Q37832481-359E7915-516E-40D3-A66F-E12CD7344988

Q37832481-3AB2DC02-374A-4224-9608-310CA66ED09C

Q37832481-3BA207A5-019C-4191-BAEF-BAA004973AA0

Q37832481-4AB5B52D-8FEA-452D-A480-6D09054835F1

Q37832481-509BB42F-5081-4D86-8CC6-85C44067FFE3

P304

Q37832481-351F4FD7-E69F-4AFB-A0B5-C174AD37091D

P31

Q37832481-08A5E65A-3993-4AE6-887B-712E1380C157

P356

Q37832481-287B84EE-9B62-46B1-AE66-5014ACA97D7F

P433

Q37832481-1531BD57-F2A1-4439-8E09-7A1BAAA9E62B

P478

Q37832481-69FEDB75-D027-4F95-9295-5524EF958691

P50

Q37832481-07B092A1-E45E-49D0-A430-B67319BA25FB

Q37832481-13067DA1-081B-4653-A8DE-3799860FC802

Q37832481-2BF5EC15-D0E7-4278-A47A-BF29EEF247BA

Q37832481-7F146B9B-442E-46D4-9B9F-ABA1D0A124D3

Q37832481-F2A5538B-1BBF-4403-BCC3-39A80DE80B14

P577

Q37832481-2846D8A1-D2B1-4EDA-B904-7495822BD916

P698

Q37832481-D061B3FF-75C2-43E4-AED0-C3F2FA4DBB22

P921

Q37832481-030DA80A-931E-4E63-8563-1CABE74AA7DE

P356

HJR.0B013E3283361DC5

P1433

European Journal of Cardiovascular Prevention and Rehabilitation

P1476

Exercise intolerance in chronic heart failure: mechanisms and therapies. Part I.

@en

P2093

Carlo Vigorito

http://www.w3.org/2001/XMLSchema#string

Giorgio Vescovo

http://www.w3.org/2001/XMLSchema#string

Luciano Dalla Libera

http://www.w3.org/2001/XMLSchema#string

Mariantonietta Cicoira

http://www.w3.org/2001/XMLSchema#string

Massimo F Piepoli

http://www.w3.org/2001/XMLSchema#string

Michele Emdin

http://www.w3.org/2001/XMLSchema#string

Piergiuseppe Agostoni

http://www.w3.org/2001/XMLSchema#string

Ugo Corrà

http://www.w3.org/2001/XMLSchema#string

Working Group 'Exercise Physio ...... Italian Society of Cardiology

http://www.w3.org/2001/XMLSchema#string

P2860

Transgenic overexpression of locally acting insulin-like growth factor-1 inhibits ubiquitin-mediated muscle atrophy in chronic left-ventricular dysfunction.

Symptoms and quality of life in heart failure: the muscle hypothesis.

Epidemiology, aetiology, and prognosis of heart failure.

Isolated ultrafiltration in moderate congestive heart failure.

The mechanisms underlying the increased ventilatory response to exercise in chronic stable heart failure.

Exercise capacity and cardiac function assessed by tissue Doppler imaging in chronic heart failure.

Endothelins: pathophysiology and treatment implications in chronic heart failure.

Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications.

Skeletal muscle apoptosis in experimental heart failure: the only link between inflammation and skeletal muscle wastage?

Water and sodium retention in edematous disorders: role of vasopressin and aldosterone.

P304

637-642

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/HJR.0B013E3283361DC5

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Giuseppe Boriani

Claudio Passino

Giovanni Quinto Villani

P577

2010-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21268774

http://www.w3.org/2001/XMLSchema#string

P921